Rakhshita Dhar
InvestorInvestor at Leaps by Bayer
Cambridge, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Rakhshita
138 people in our graph share verified history with Rakhshita — schools, employers, funds. One of them is your warm intro.
Diana BerishaunlockedRakhshita: together at Georgetown (2009)
%20(1)%20(1).png)
×2Rakhshita: together at Leaps by Bayer
×7Rakhshita: together at Georgetown
×2Rakhshita: together at NextPoint Therapeutics
Experience
- Leaps by BayerVice President & Head of Healthcare Venture Investmentscurrent2021 — present
- RocheDirector Of Business Development2017 — 2021Greater Boston
- MassBioSenior Director of Innovation Services2017Cambridge, MA
- MassBioDirector of Innovation Services2014 — 2017
- MassBioManager of Innovation Services2010 — 2014
- Editas MedicineBusiness Development Consultant2015 — 2017
- Flagship VentureLabsBusiness Development Consultant2015 — 2017
- Adjuvant Global AdvisorsBusiness Development Intern2010bethesda, md
Skills & more
Lifesciences5Biotechnology24Market Research17Biotechnology Industry12Life Science Industry12Strategic Partnerships14Program Management6Business Development21Biopharmaceuticals16Commercialization9Medical Devices4Venture Capital6
+5 more
Drug DevelopmentLicensingCorporate DevelopmentLife SciencesPharmaceutical IndustryFrom Rakhshita's professional profile.
Colleagues at Leaps by Bayer
Network2
Investors connected to Rakhshita in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Rakhshita Dhar?
- Investor at Leaps by Bayer
- Where does Rakhshita Dhar work?
- Rakhshita Dhar is Investor at Leaps by Bayer.
- What check size does Rakhshita Dhar write?
- Rakhshita Dhar typically writes checks of $100K – $5M.
- Where did Rakhshita Dhar go to school?
- Rakhshita Dhar studied at Georgetown University (MS, Biochemistry and Molecular Biology); University of Mumbai (BS, Biochemistry).
Same school
Also attended Georgetown University631
Trae StephensPartner at Founders Fund and co-founder of AndurilLuciana LixandruPartner at Sequoia CapitalKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Tobi CokerDeal Partner at Felicis VenturesAna AndreescuInvestor at Index VenturesDiana BerishaInvestor at Spark Capital
+ 625 more
Shared employers
Also worked at Roche147
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 141 more
Also worked at MassBio11
Christopher de SouzaDirector at Broadview VenturesGlenn BatchelderVenture Partner at Pivotal Life SciencesMartin HeideckerCIO at AMR Action FundChandra RamanathanAdvisor, Biotech at Iaso VenturesJanice BourqueManaging Director of Life Sciences, Hercules Capital at Foreground CapitalNathan DavisAnalyst at RA Capital
+ 5 more
Also worked at Editas Medicine7
Kevin BittermanPartner at Atlas VentureDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesAlexandra (Sandra) GlucksmannAdvisory Partner at Adjuvant CapitalAndrew HackPartner at Bain Capital Life SciencesMichael C. Bassik, Ph.D.Scientific Founder at Stylus MedicineGeorge ChurchScientific Advisor / Co-Founder at Eugit Therapeutics
+ 1 more
